Vanda Pharmaceuticals Inc Azioni (VNDA) Dati Finanziari
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues | 38.17%69.82 | 50.53 | 51.72 | 57.22 | 56.26 |
17.07%59.58 | 71.84 | 68.36 | - | - | |
| Selling, General, and Administrative | 17.07%59.58 | 71.84 | 68.36 | - | - |
| Research and Development | 25.25%27.62 | 36.95 | 28.44 | - | - |
| Costs And Expenses | 18.37%93.34 | 114.34 | 101.94 | 97.57 | 87.54 |
| Operating Income/Loss | 63.14%-23.52 | -63.81 | -50.22 | -40.35 | -31.28 |
| Income/Loss From Continuing Operations Before Tax | 64.11%-22.39 | -62.38 | -48.42 | -38.00 | -28.39 |
| Income Tax Expense/Benefit, Deferred | - | - | - | 103.19 | -5.97 |
| Income Tax Expense/Benefit | 34.88%0.17 | 0.13 | 0.14 | 103.19 | -5.80 |
63.91%-22.56 | -62.51 | -48.57 | -141.19 | -22.59 | |
| Attributable To Parent | 63.91%-22.56 | -62.51 | -48.57 | -141.19 | -22.59 |
| Basic Average Shares | 0.40%60.47 | 60.23 | 59.46 | 0.06 | 59.09 |
| Diluted Average Shares | 0.40%60.47 | 60.23 | 59.46 | 0.06 | 59.09 |
| Basic Earnings Per Share | 64.42%-0.37 | -1.04 | -0.82 | -2.39 | -0.38 |
| Diluted Earnings Per Share | 64.42%-0.37 | -1.04 | -0.82 | -2.39 | -0.38 |